New perspective on exploring the predictive factors of blood pressure reduction during CPAP treatment in people with severe OSA and hypertension: a prospective observational study.
sleep apnoea
Journal
BMJ open respiratory research
ISSN: 2052-4439
Titre abrégé: BMJ Open Respir Res
Pays: England
ID NLM: 101638061
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
received:
21
11
2022
accepted:
28
04
2023
medline:
15
5
2023
pubmed:
12
5
2023
entrez:
11
5
2023
Statut:
ppublish
Résumé
The predictive factors of blood pressure (BP) response to continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA) are still being explored. We aimed to assess the antihypertensive effect of CPAP considering the obstructive respiratory event-triggered BP surge profiles in 130 subjects with severe OSA and untreated hypertension. Nocturnal BP was monitored continuously and synchronised with polysomnography. Event-triggered BP surge profiles were studied: BP surge as the value of event-related systolic BP (SBP) elevation; BP index as the number of BP surge events of ≥10 mm Hg per hour. Patients were then divided into two groups according to the median BP index (high and low BP surge groups) and assigned to 4 weeks of CPAP. Changes in BPs and plasma biomarkers were compared. After the initial evaluation, patients with a better BP response in the high BP surge group were then followed up for the second evaluation at 24 months. Overall, a modest decrease was observed in both office and asleep BPs at the 4-week follow-up; however, BPs dropped more markedly in patients in the high BP surge group than those in the low BP surge group, in both office SBP (5.3 mm Hg vs 2.2 mm Hg, p=0.003) and diastolic BP (4.0 mm Hg vs 1.2 mm Hg, p<0.001), especially the asleep SBP (9.0 mm Hg vs 2.1 mm Hg, p<0.001). For 30 cases in the high BP surge group, optimal BP control was achieved in 60.0% of patients and BP<140/90 mm Hg reached up to 83.3% after 24 months of CPAP. Linear regression revealed that BP index was significantly associated with BP decrease during CPAP treatment. Our results suggested that high event-triggered BP surge was a sensitive predictor of BP response to CPAP in patients with severe OSA and untreated hypertension. Clinical Trials.gov Identifier: NCT03246022; https://clinicaltrials.gov/ct2/show/NCT03246022?term=NCT+03246022&draw=2&rank=1.
Sections du résumé
BACKGROUND
The predictive factors of blood pressure (BP) response to continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA) are still being explored. We aimed to assess the antihypertensive effect of CPAP considering the obstructive respiratory event-triggered BP surge profiles in 130 subjects with severe OSA and untreated hypertension.
METHODS
Nocturnal BP was monitored continuously and synchronised with polysomnography. Event-triggered BP surge profiles were studied: BP surge as the value of event-related systolic BP (SBP) elevation; BP index as the number of BP surge events of ≥10 mm Hg per hour. Patients were then divided into two groups according to the median BP index (high and low BP surge groups) and assigned to 4 weeks of CPAP. Changes in BPs and plasma biomarkers were compared. After the initial evaluation, patients with a better BP response in the high BP surge group were then followed up for the second evaluation at 24 months.
RESULTS
Overall, a modest decrease was observed in both office and asleep BPs at the 4-week follow-up; however, BPs dropped more markedly in patients in the high BP surge group than those in the low BP surge group, in both office SBP (5.3 mm Hg vs 2.2 mm Hg, p=0.003) and diastolic BP (4.0 mm Hg vs 1.2 mm Hg, p<0.001), especially the asleep SBP (9.0 mm Hg vs 2.1 mm Hg, p<0.001). For 30 cases in the high BP surge group, optimal BP control was achieved in 60.0% of patients and BP<140/90 mm Hg reached up to 83.3% after 24 months of CPAP. Linear regression revealed that BP index was significantly associated with BP decrease during CPAP treatment.
CONCLUSIONS
Our results suggested that high event-triggered BP surge was a sensitive predictor of BP response to CPAP in patients with severe OSA and untreated hypertension.
TRIAL REGISTRATION NUMBER
Clinical Trials.gov Identifier: NCT03246022; https://clinicaltrials.gov/ct2/show/NCT03246022?term=NCT+03246022&draw=2&rank=1.
Identifiants
pubmed: 37169401
pii: 10/1/e001560
doi: 10.1136/bmjresp-2022-001560
pmc: PMC10186402
pii:
doi:
Substances chimiques
Antihypertensive Agents
0
Banques de données
ClinicalTrials.gov
['NCT03246022']
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Hypertension. 2018 Nov;72(5):1133-1140
pubmed: 30354806
Sleep Med. 2021 Aug;84:1-7
pubmed: 34090008
Eur J Appl Physiol. 2012 Jan;112(1):309-15
pubmed: 21556814
Conf Proc IEEE Eng Med Biol Soc. 2006;2006:6049-52
pubmed: 17946738
JAMA. 2012 May 23;307(20):2161-8
pubmed: 22618923
Lancet. 2009 Jan 3;373(9657):82-93
pubmed: 19101028
Eur Respir J. 2019 Jul 25;54(1):
pubmed: 31097515
JAMA. 2013 Dec 11;310(22):2407-15
pubmed: 24327037
Sleep Med Rev. 2021 Aug;58:101446
pubmed: 33607443
Sleep Breath. 2018 Dec;22(4):1045-1052
pubmed: 29524090
J Am Coll Cardiol. 2015 Sep 1;66(9):1023-32
pubmed: 26314530
Chest. 2006 Jun;129(6):1459-67
pubmed: 16778262
Auton Neurosci. 2016 Jan;194:38-45
pubmed: 26774324
J Clin Sleep Med. 2020 Jul 15;16(7):1055-1062
pubmed: 32105212
Chest. 2014 Apr;145(4):762-771
pubmed: 24077181
Sleep Med. 2018 Jul;47:11-18
pubmed: 29880142
Lancet Respir Med. 2013 Mar;1(1):61-72
pubmed: 24321805
Ann Intern Med. 1976 Dec;85(6):714-9
pubmed: 999107
J Clin Sleep Med. 2012 Oct 15;8(5):587-96
pubmed: 23066375
JAMA. 2000 Apr 12;283(14):1829-36
pubmed: 10770144
Respirology. 2015 Aug;20(6):889-95
pubmed: 26073295
Sleep Med Rev. 2015 Jun;21:23-38
pubmed: 25220580
Eur Respir J. 2017 Oct 5;50(4):
pubmed: 28982776
BMJ. 2010 Nov 24;341:c5991
pubmed: 21106625
Eur Respir J. 2020 May 7;55(5):
pubmed: 32079643
Hypertension. 2015 Apr;65(4):736-42
pubmed: 25601933
Hypertension. 2003 Dec;42(6):1206-52
pubmed: 14656957
J Clin Invest. 2014 Apr;124(4):1454-7
pubmed: 24691480
J Hypertens. 2018 Jan;36(1):199-204
pubmed: 28800040
Clin Auton Res. 2018 Aug;28(4):375-384
pubmed: 29429026
Sleep Breath. 2012 Dec;16(4):1105-12
pubmed: 22033628
Blood Press Monit. 2015 Oct;20(5):291-4
pubmed: 25932885
Sleep Breath. 2021 Mar;25(1):151-161
pubmed: 32297145